Risk Stratification of Stent PCI Surgery Outlined

Prof. Ran Kornowski, M.D, FACC, FESC on behalf of the coauthors Chairman - Division of Cardiology, Rabin Medical Center, Petah-Tikva, IsraelMedicalResearch.com Interview with:
Prof. Ran Kornowski, M.D, FACC, FESC on behalf of the coauthors

Chairman – Division of Cardiology,
Rabin Medical Center, Petah-Tikva, Israel

Medical Research: What is the background for this study?

Prof. Kornowski:  Over the years, the PCI procedure went-through many progresses. Among those are some angioplasty techniques, generalize use of stents and drug eluting stents, and adjuvant novel antithrombotic therapy. Unmistakably, these were associated with an overall improved PCI outcome. As many of the data on PCIs’ adverse outcomes predictors come from predates studies, we sought to update this matter.

Medical Research: What are the main findings?

Prof. Kornowski: This study confirms the influence of advanced age, diabetes-mellitus and  urgent settings (i.e. acute coronary syndromes) on PCI long term outcome. However, we found that their effect extent is modest while supplementary predictors such as anemia (even mild), chronic kidney injury and echocardiographic findings of left ventricular dysfunction have a greater effect on contemporary PCI prognosis.

Medical Research: What should clinicians and patients take away from your report?

Prof. Kornowski: Risk stratification of PCI patients should take account of LV dysfunction, chronic kidney injury and anemia (even mild), as these factors have stronger association with adverse outcome than older age and urgent PCI settings. Contemporary drug eluting stents may provide a sustained benefit and should be used whenever possible..

Citation:

Predictors of Long Term Outcomes in 11,441 Consecutive Patients Following Percutaneous Coronary Interventions

Last Updated on February 9, 2015 by Marie Benz MD FAAD